AstraZeneca’s Lokelma Gets Approval in Japan for Hyperkalaemia

AstraZeneca PLC AZN announced that the Japanese regulatory authority has granted marketing approval to Lokelma (sodium zirconium cyclosilicate) for the treatment of patients with hyperkalaemia in Japan. Hyperkalemia is a serious condition characterized by high levels of potassi